MetaCap

Who Owns 4D Molecular Therapeutics Stock?

NASDAQ: FDMTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

10.23-0.49 (-4.57%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
103.88%
Institutional holders
227
  • Institutions 97.3%
  • Insiders 2.7%
  • Public and other 0.0%

Who owns 4D Molecular Therapeutics stock?

Institutional investors own about 103.9% of 4D Molecular Therapeutics's shares, spread across 227 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 2.67% of FDMT.

The largest institutional holders are Janus Henderson Group Ltd. (10.17%), RA Capital Management, L.P. (8.96%) and Blackrock Inc. (8.38%). Together, the top 10 institutions control 61.3% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their FDMT positions and 4 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of FDMT

4D Molecular Therapeutics top institutional holders
InstitutionShares% HeldChange
Janus Henderson Group Ltd.5.73M10.17%+9.3%
RA Capital Management, L.P.5.05M8.96%0.0%
Blackrock Inc.4.72M8.38%+3.9%
Goldman Sachs Group Inc3.93M6.97%-7.7%
Novo Holdings A/S3.00M5.32%-7.7%
BVF Inc.2.88M5.11%0.0%
State Street Corporation2.47M4.38%-15.2%
Adage Capital Partners GP L.L.C.2.29M4.06%+1.8%
T. Rowe Price Investment Management, Inc.2.27M4.02%-9.8%
Trails Edge Capital Partners, LP2.23M3.95%0.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of FDMT

4D Molecular Therapeutics top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.59M2.82%
iShares Trust-iShares Russell 2000 ETF1.19M2.10%
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF1.17M2.08%
JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund865.42K1.53%
T. Rowe Price Small-Cap Stock Fund, Inc.681.92K1.21%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund501.54K0.89%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund460.48K0.82%
T. Rowe Price Small-Cap Value Fund, Inc.455.27K0.81%
iShares Trust-iShares Russell 2000 Value ETF428.65K0.76%
iShares Trust-iShares Biotechnology ETF390.90K0.69%

Frequently asked questions

Who is the largest shareholder of 4D Molecular Therapeutics?

Janus Henderson Group Ltd. is the largest institutional shareholder of FDMT, owning 10.17% of shares outstanding (5.73M shares) as of its latest 13F filing.

What percentage of 4D Molecular Therapeutics is owned by institutions?

Institutions own about 103.9% of FDMT shares and 106.7% of the public float.

How much of 4D Molecular Therapeutics do insiders own?

Insiders, such as officers and directors, own about 2.67% of FDMT shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related